Cellomatics Biosciences provides specialist blood brain barrier CRO services for pharmaceutical and biotechnology companies studying drug transport, permeability, and barrier function. Its research capabilities support the development and use of relevant in vitro blood brain barrier models for evaluating how therapeutic candidates interact with this selective biological interface. The company’s experienced scientific team can support assay development, experimental studies, and project-specific research requirements.